Showing results (761-770 of 3,016) with videos related to
Sort By:
Pageof 302
Current Drug Targets|January 17, 2003
Molecular aspects of drug recognition by specific T cellsMarkus Britschgi, Salome von Greyerz, Christoph Burkhart, et al.Current Drug Targets|March 20, 2003
Tumor cell hypoxia and the hypoxia-response signaling system as a target for prostate cancer therapyAristotelis G Anastasiadis, Debra L Bemis, Brian C Stisser, et al.Current Drug Targets|March 20, 2003
TGF-betal/Smad signaling in prostate cancerDiana Bello-DeOcampo, Donald J TindallCurrent Drug Targets|November 24, 2018
Investigational Hypoxia-Activated Prodrugs: Making Sense of Future DevelopmentMin-Xia Su, Le-Le Zhang, Zhang-Jian Huang, et al.Current Drug Targets|April 6, 2019
Anti-tumor Drug Targets Analysis: Current Insight and Future ProspectSheng Wang, Dexi Zhou, Zhenyu Xu, et al.Current Drug Targets|March 22, 2019
Steroids and Postoperative Complications in IBDAntonio López-SanrománCurrent Drug Targets|February 27, 2019
Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic DiseasesArunaksharan NarayanankuttyCurrent Drug Targets|September 28, 2019
Molecular and Biological Functions of Melatonin in Endometrial CancerParisa Maleki Dana, Fatemeh Sadoughi, Moein Mobini, et al.Current Drug Targets|August 11, 2019
p19INK4d: More than Just a Cyclin-Dependent Kinase InhibitorXu Han, Yijin Kuang, Huiyong Chen, et al.Current Drug Targets|January 26, 2021
Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for TherapyArmita M Gorabi, Mohsen Ghanbari, Thozhukat Sathyapalan, et al.Pageof 302